Ceritinib is a selective anaplastic lymphoma kinase (ALK) inhibitor that blocks ALK-driven tumor cell proliferation. It is primarily used for the treatment of ALK-positive non-small cell lung cancer (NSCLC), especially in patients resistant to prior ALK inhibitors.

Ceritinib API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.